Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chiara Alì
Institution:
Altamedica Artemisia
Observed institutions:
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”,
IRCCS Humanitas Research Hospital,
Altamedica Artemisia
ORCID:
0009-0002-0355-6533
Observed ORCID:
0009-0002-0355-6533
OpenAlex ID:
A5026326398
Heme catabolism by tumor-associated macrophages controls metastasis formation
2021
·
Francesca Maria Consonni
, Augusto Bleve
, et al.
·
Nature Immunology
·
131
RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
·
Cancer Discovery
·
30
PDF
Prenatal Trio Exome Sequencing in Low‐Risk Pregnancies: Diagnostic Yield and Clinical Implications
2026
·
Katia Margiotti
, Marco Fabiani
, et al.
·
Clinical Genetics
PDF
Figure S10 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S8 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S3 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S1 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S2 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Data from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
Table S2 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S7 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S5 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S11 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S6 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Table S1 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
Figure S9 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Figure S4 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Table S4 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Table S3 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
Table S5 from RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
2025
·
Augusto Bleve
, Martina Incerti
, et al.
PDF
Show more works
View as search
Works count:
20
Citation count:
159
H-index:
2
I10-index:
2
Year
Topic
Type